CommercialCoverageMedium impact
06.03.04o, Apheresis Therapy
Independence Blue Cross·Hematology, Oncology, Nephrology +1 more·Medical Policy
Effective date
Mar 17, 2025
We identified it
Jun 19, 2026
Summary
Commercial insurance has updated the medical necessity criteria for Apheresis Therapy procedures. The policy change will modify coverage requirements and determination processes for apheresis treatments, requiring billing teams to review and adjust their authorization and documentation practices.
Action Required
Before March 17, 2025: Billing team must review updated medical necessity criteria for apheresis therapy claims. Update prior authorization workflows and documentation requirements in billing system. Ensure providers are aware of new criteria to prevent claim denials. Monitor the full policy details at the provided URL for specific requirements.